The Walden Group is pleased to announce that it was engaged by Katalyst Surgical, LLC and initiated its merger with an affiliate of Carl Zeiss Meditec AG, one of the world’s leading medical technology companies traded on the German Stock Exchange. Katalyst Surgical is a leader in vitreoretinal instruments, fiberoptic illumination, innovative light sources and other ophthalmic surgical technologies. Its …

Integer Holdings Corporation, a $1.2b device outsource manufacturer has acquired Ireland-based Aran Biomedical, a producer of proprietary medical textiles, high precision biomaterial coverings and coatings and advanced metal and polymer braiding for implantable devices.  Aran Biomedical enables Integer to penetrate high growth cardiovascular markets including structural heart, neurovascular, peripheral vascular and endovascular and also general surgery applications.  Deal terms – $130m …

Custom contract manufacturer and injection molder Teamvantage has acquired MMD Medical, a contract manufacturer of components for large medical OEMs. The deal will enable Teamvantage to create a one-stop-shop with differentiated precision manufacturing capabilities. Teamvantage is a portfolio company of private equity firm Graham Partners. MMD Medical’s capabilities include injection molding, precision machining and mold building to scale the Teamvantage …

LumiThera Inc, a manufacturer of photobiomodulation (PBM) technologies that treat ocular damage and disease, has acquired Diopsys, Inc. a maker of electrophysiology (ERG) devices that analyze visual and neuro-visual disorders. The deal adds an established commercial U.S. sales force to LumiThera’s EU sales team and a complimentary diagnostic and monitoring capability to LumiThera’s PBM platform.  LumiThera’s device is being studied …

The Walden Group is pleased to provide access to its 2021 Year-end Strategic Healthcare M&A Report, which includes:       Key Market Developments       The Most Important M&A Deals       What the Leading CEOs are Saying       Top Deals > $100m in Transaction Value Announced or Closed in 2021       Performance …

DePuy Synthes, the orthopedics and neurosurgery division of J&J, has acquired CrossRoads® Extremity Systems from its majority investor, Healthpoint Capital. The deal adds a portfolio of implants and instruments for lower-extremity procedures. In December 2021, DePuy Synthes acquired Israeli-based OrthoSpin, maker of an robotic orthopedic strut systems for external circular fixations . CrossRoads’ EcoSMART instruments are reusable via sterile processing …

Smith & Nephew, a $4.6b UK-based sports medicine, joint repair, surgical access and woundcare technology producer, has acquired, Engage Surgical, a developer of a proprietary cementless partial knee system. The deal distinguishes Smith & Nephew as the only medical device company offering both cemented and cementless partial knee implants in the US, as well as robotics-assistance through the CORI Surgical …

Exact Sciences, a $876m developer of cancer screening and diagnostic test products to detect colorectal, prostate and other cancers, has acquired PreventionGenetics, a genetic testing laboratory. The deal complements Exact Sciences’ advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing. PreventionGenetics is a CLIA-certified and CAP-accredited clinical DNA testing laboratory, providing more than 5,000 predefined genetic tests …

Quidel Corporation, a $1.87b maker of point-of-care diagnostics for infectious diseases, women’s health, and gastrointestinal diseases, is acquiring Ortho Clinical Diagnostics, a $2b in vitro diagnostics company focused on equipment for blood testing. The deal complements Quidel’s existing product offerings and expands its global presence. Ortho Clinical Diagnostics offers automated instruments, assays, reagents, and other consumables. Both companies have been …

Koninklijke Philips N.V, a $22b Netherlands-based producer of medical imaging and diagnostic solutions acquired Vesper Medical Inc., a developer of minimally-invasive peripheral vascular devices. Vesper’s modular Duo system involves a self-expanding stent that addresses a broader range of vein shapes and sizes than alternative products. Malfunctioning valves or obstructions within veins can cause blood to pool in the legs leading …